Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

Ontology Browser

Term:
Parent Terms Term With Siblings Child Terms
(+)-makassaric acid 
(+)-subersic acid 
1,4-diamino-2,3-dicyano-1,4-bis(phenylthio)butadiene 
1,8-dihydroxy-4-nitroxanthen-9-one 
2-(\{2-[(3-hydroxyphenyl)amino]pyrimidin-4-yl\}amino)benzamide 
aminopurvalanol 
Aurora kinase inhibitor +   
Any protein kinase inhibitor that inhibits the action of an Aurora kinase (a group of serine/threonine kinases that are essential for cell proliferation).
CMB4563 
CZC8004 
DMH1 
EC 2.7.10.* (protein-tyrosine kinase) inhibitor +   
EC 2.7.11.* (protein-serine/threonine kinase) inhibitor +   
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor +   
epidermal growth factor receptor antagonist +   
erlotinib +   
erlotinib hydrochloride  
gamma-mangostin 
miltefosine  
mTOR inhibitor +   
pelitinib +  
piceatannol +  
purvalanol B 
quercetin +   
Ro 320-1195 +  
salt-inducible kinase 2 inhibitor +  
sangivamycin 
tyrosine kinase inhibitor +   
XMD8-92 

Synonyms
Related Synonyms: Aurora kinase inhibitors
Xrefs: PMID:19369091 "Europe PMC" ;   PMID:21147253 "Europe PMC" ;   PMID:22350019 "Europe PMC"

paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.